13F-HR 1 expo.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: March 31, 2010 Check here if Amendment |_|;Amendment Number:_____ This Amendment (Check only one.): |_| is a restatement. |_| adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Expo Capital Management, LLC Address: 11111 Santa Monica Blvd. Suite 1470 Los Angeles, CA 90025 13F File Number: 28-12799 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Andrew Bzura Title: Chief Operating Officer Phone: 310-201-7911 Signature, Place, and Date of Signing: /s/ Andrew Bzura Los Angeles, CA May 14, 2010 ----------------------------------- ---------------- ------------------ [Signature] [City, State] [Date] Report Type (Check only one.): |X| 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) |_| 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) |_| 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 Form 13F Information Table Entry Total: 26 Form 13F Information Table Value Total: $229,286 (thousands) List of Other Included Managers: None Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. NONE Expo Capital Management, LLC March 31, 2010 FORM 13F INFORMATION TABLE

TITLE OF VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER ~~TITLE OF~~ CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE ------------------------------------------------------------------------------------------------------------------------------~~------~~ ~~AETNA INC COM 00817Y108 $5,548 175,000 SH Sole 175,000~~ ALEXION PHARMACEUTICALS INC COM 015351109 $78,~~811~~835 ~~160~~162,~~000~~500 SH Sole ~~160~~162,~~000~~500 ALLERGAN INC COM 018490102 $78,~~561~~786 ~~120~~134,~~000~~500 SH Sole ~~120~~134,~~000~~500 AMERICAN MED SYS HLDGS INC COM 02744M108 $78,~~041~~389 ~~365~~451,~~000~~500 SH Sole ~~365~~451,~~000~~500 AMERIGROUP CORP COM 03073T102 $710,~~144~~604 ~~265~~319,000 SH Sole ~~265~~319,000 ~~AMGEN~~BIOGEN IDEC INC COM ~~031162100~~09062X103 $58,~~657~~293 ~~100~~144,~~000~~500 SH Sole ~~100~~144,~~000~~500 CELERA CORP COM 15100E106 $11,569 1,629,500 SH Sole 1,629,500 CENTENE CORP DEL COM 15135B101 $78,~~410~~775 ~~350~~365,000 SH Sole ~~350~~365,000 CEPHALON INC COM 156708109 $67,~~554~~761 ~~105~~114,~~000~~500 SH Sole ~~105~~114,~~000~~500 CEPHEID COM 15670R107 $8,085 462,500 SH Sole 462,500 CONCEPTUS INC COM 206016107 $68,~~847~~174 ~~365~~409,~~000~~500 SH Sole ~~365~~409,~~000~~500 CUBIST PHARMACEUTICALS INC COM 229678107 $58,~~691~~723 ~~300~~387,000 SH Sole ~~300~~387,000 ~~EDWARDS~~ECLIPSYS ~~LIFESCIENCES~~ CORP COM ~~28176E108~~278856109 $58,~~645~~340 65419,~~000~~500 SH Sole 65419,~~000~~500 ENDO PHARMACEUTICALS HLDGS INC COM 29264F205 $68,~~156~~209 ~~300~~346,~~000~~500 SH Sole ~~300~~346,~~000~~500 ~~EXELIXIS~~EV3 INC COM ~~30161Q104~~26928A200 $58,~~712~~715 ~~775~~549,~~000~~500 SH Sole ~~775~~549,~~000~~500 ~~HMS~~HUMAN ~~HLDGS~~GENOME ~~CORP~~SCIENCES ~~COM 40425J101 $7,304 150,000 SH Sole 150,000 HUMANA~~ INC COM ~~444859102~~444903108 $58,~~486~~441 ~~125~~279,~~000~~500 SH Sole ~~125~~279,~~000~~500 ~~INCYTE~~KING ~~CORP~~PHARMACEUTICALS INC COM ~~45337C102~~495582108 $68,~~605~~208 ~~725~~698,000 SH Sole ~~725~~698,000 MEDICIS PHARMACEUTICAL CORP CL A NEW 584690309 $68,~~763~~366 ~~250~~332,~~000~~500 SH Sole ~~250~~332,~~000~~500 MYRIAD GENETICS INC COM 62855J104 $8,~~479~~393 ~~325~~349,000 SH Sole ~~325~~349,000 ~~OSI~~PERKINELMER ~~PHARMACEUTICALS~~ INC COM ~~671040103~~714046109 $68,~~212~~724 ~~200~~365,000 SH Sole ~~200~~365,000 ~~PERKINELMER~~PHARMACEUTICAL PROD DEV INC COM ~~714046109~~717124101 $69,~~692~~389 ~~325~~395,~~000~~500 SH Sole ~~325~~395,~~000~~500 SALIX PHARMACEUTICALS LTD COM 795435106 $79,~~617~~331 ~~300~~250,~~000~~500 SH Sole ~~300~~250,~~000~~500 SHIRE PLC ~~Sponsored~~SPONSPORED ADR 82481R106 $68,~~457~~614 ~~110~~130,~~000~~500 SH Sole ~~110~~130,~~000~~500 ~~SONOSITE~~THORATEC ~~INC~~CORP COM ~~83568G104~~885175307 $58,~~908~~864 ~~250~~265,000 SH Sole ~~250~~265,000 ~~UNITEDHEALTH GROUP INC COM 91324P102 $5,334 175,000 SH Sole 175,000~~ WATERS CORP COM 941848103 $59,~~576~~253 90137,000 SH Sole 90137,000 WATSON PHARMACEUTICALS INC COM 942683103 $78,~~328~~939 ~~185~~214,000 SH Sole ~~185~~214,000 ~~WELLPOINT~~WELLCARE ~~INC~~HEALTH ~~COM~~PLANS ~~94973V107 $5,829 100,000 SH Sole 100,000 WRIGHT MED GROUP~~ INC COM ~~98235T107~~94946T106 $59,~~682~~506 ~~300~~319,000 SH Sole ~~300~~319,000 ~~ZIMMER HLDGS INC COM 98956P102 $5,615 95,000 SH Sole 95,000~~

Filing Compare · EXPO CAPITAL MANAGEMENT LLC